###### Strengths and limitations of this study

-   This is the first study to establish the cut-off point of a cognitive screening instrument (Montreal Cognitive Assessment (MoCA)-Beijing) against a 'gold standard' neuropsychological evaluation in Chinese patients with mild stroke and transient ischaemic attack within 2 weeks after index cerebrovascular event.

-   A cut-off point of 22/23 on MoCA-Beijing provided good sensitivity and specificity.

-   The study was limited by its small sample size (n=102), thereby not permitting the examination of age-adjusted and education-adjusted cut-off points.

Introduction {#s1}
============

Non-disabling cerebrovascular events, which include mild ischaemic stroke (median National Institute of Health Stroke Scale (NIHSS)=2, median modified Rankin Score (mRS)=2))[@R1] and transient ischaemic attack (TIA), generally result in either short-lasting or mild neurological symptoms,[@R1] but these patients are at an increased risk of a recurrent cerebrovascular event. The patients therefore receive considerable medical attention and treatment for physical symptoms and risk factors. However, their cognitive function is often neglected, especially in the acute stroke phase. In China, there are approximately 9 million patients diagnosed with mild stroke every year.[@R2] A recent study has shown that the prevalence of TIA is 2.27%.[@R3] This is a major public health problem which has increased the healthcare and economic burden, especially when cognitive impairment (CI) is taken into consideration. CI after stroke/TIA has a reported prevalence ranging from 21% to 70%.[@R4] About one in three patients with TIA has an impairment of ≥1 cognitive domain(s) within 3 months after TIA.[@R5] Therefore, early detection of CI at acute stroke phase is the first step to an intensive reduction of vascular risk factors and improved prognosis.[@R6]

The Montreal Cognitive Assessment (MoCA) is a brief cognitive instrument recommended for screening for CI in patients with stroke or TIA.[@R7] Several studies have compared the discriminant abilities of the MoCA and the Mini-Mental State Examination (MMSE) for screening post-stroke CI, and most studies have demonstrated that the MoCA is superior or equivalent to the MMSE for the detection of CI after stroke.[@R6] [@R8] Furthermore, the MoCA has been reported to be sensitive to changes in acute temporary CI after mild stroke/TIA, whereas, the MMSE is reportedly not.[@R11] On the other hand, a recent meta-analysis showed that all CI screening tests performed similarly in patients with stroke.[@R12] The MoCA at its conventional cut-off point (\<26/30), has excellent sensitivity (0.95) but suboptimal speciﬁcity (0.45). By comparison, the adapted MoCA cut-off point (\<22/30) improved speciﬁcity (0.78) while maintaining good sensitivity (0.84). However, there is no data on the discriminant ability of the MoCA for detecting CI determined by a formal neuropsychological evaluation in the Chinese population at the acute stroke phase. Therefore, this study validates the Chinese Beijing version of the MoCA (MoCA-Beijing) against a 'gold' standard neuropsychological evaluation to detect CI after acute mild stroke and TIA.

Methods {#s2}
=======

Participants {#s2a}
------------

Patients were recruited consecutively from the stroke ward in the Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China, from 1 December 2014 to 30 July 2015.

The inclusion criteria for patients were 18 years of age or older, with an ischaemic mild stroke or TIA within 7 days. Patients\' stroke/TIA were diagnosed by neurologists, and confirmed with brain CT or MRI. An eligible patient also had an available informant who was knowledgeable about the patient\'s medical history and cognitive status, and had met the patient on a weekly basis for at least 5 years prior to the recruitment. The acute ischaemic stroke was diagnosed according to WHO criteria.[@R1] [@R14] TIA was defined by the American Stroke Association.[@R15]

The exclusion criteria for patients were stroke mimics (ie, seizures, migraine), illiteracy or any major physical and mental conditions that may impede cognitive assessments. Out of the 119 consecutive patients with stroke who were approached, a majority of patients were recruited into our study (n=102). The reasons for exclusion (n=17) were as follows: major depression defined by a Hamilton Depression Rating Score[@R16] ≥17 (n=8), severe hearing impairment (n=4), achromatopsia (n=3) and illiteracy (n=2). Of the sample of 102, were comprised 80 patients with acute mild stroke and 22 patients with TIA.

This study was approved by the Beijing Tiantan Hospital ethics review board. Informed written consent was obtained from all participants.

Procedure {#s2b}
---------

### Demographics and clinical profile {#s2b1}

Demographic information including age, sex, educational level, cardiovascular risk factors as well as clinical information, was collected. The severity of neurological impairment was evaluated by the NIHSS[@R17] within 24 hours after admission. The aetiological subtypes of ischaemic stroke were identified as large atherothrombotic infarction (LAA), cardiogenic embolism (CE), artery occlusion (SAO), undetermined type (UND), and other type (OC), according to the Trial of ORG 10 172 in Acute Stroke Treatment criteria.[@R18] All patients underwent brain MRI on a 3.0 T MR scanner. Imaging sequences included three-dimensional time-of-flight MR angiography (MRA), axial T2-weighted, T1-weighted imaging, fluid-attenuated inversion recovery sequences and diffusion-weighted imaging. All the above sequences, except MRA, had a 5 mm slice thickness and a 1.5 mm interslice gap.

### Neuropsychological assessment {#s2b2}

A formal battery of neuropsychological tests in line with the National Institute of Neurological Disorders and Stroke and the Canadian Stroke Network[@R7] neurocognitive harmonisation standards were included to establish CI. This test battery was administered by trained neurologists and was completed within 14 days after the acute stroke/TIA.[@R7] The average assessment time from the index event was 10 days (median 2 days). The individual tests of the formal battery of neuropsychological test battery are as follows: (1) Auditory Verbal Learning Test for immediate and delay verbal memory;[@R19] (2) Rey-Osterrieth Complex Figure Test (RCFT)-delayed Recall for visual memory;[@R20] (3) RCFT copy for visuospatial ability;[@R20] (4) Animal Fluency Test[@R21] and Boston Naming Test (30 item)[@R22] for language; (5) Symbol Digit Modalities Test for visuomotor speed;[@R23] (6) Chinese modified version of the Trail Making Test (TMT)-A,[@R24] TMT-B,[@R24] Stroop Color-Word Test-Chinese version (CWT)-Color and Stroop CWT-C correct numbers[@R24] for attention/executive function.

The MoCA-Beijing[@R25] requires educational adjustment, that is, one point was added to the total score for those with education \<12 years.[@R26] The modification of MoCA-Beijing from the original MoCA were: (1) visuospatial/executive function domain: the alphabet letters are replaced with Chinese characters (甲/乙/丙/丁/戊) which contain the same sequential meanings as 'A/B/C/D/E' in English; (2) attention domain: numbers are used instead of English alphabet letters; (3) language domain: in the verbal fluency task, the phonemic fluency task that requires participants to generate words beginning with the letter F is replaced by the semantic fluency task requiring participants to produce as many animals as possible in 60 s. Using the conventional cut-off score of \<26, the MoCA-Beijing demonstrated an excellent sensitivity of 90.4%, however, suboptimal specificity was of 31.3%.[@R27] The formal battery of neuropsychological tests and MoCA-Beijing were conducted at the same time, and the formal battery of neuropsychological tests were administered by trained neurologists blinded to the MoCA scores.

### Functional assessment {#s2b3}

Basic daily functioning was assessed by the Katz basic activities of daily living (basic ADL) scale,[@R28] with six basic items, and complex function was assessed by Lawton and Brody instrumental activities of daily living (instrumental ADL) scale,[@R29] with eight instrumental items. Four levels of grading of ADLs were adopted for assessment:1=independent; 2=need for supervision; 3=need for help; 4=unable. The total scores range from 14 to 56. Total scores of ≥16 reflect impaired Alzheimer\'s disease, with higher scores on the ADL scale indicating more severe impairment of daily functioning.

Diagnosis of vascular cognitive impairment {#s2c}
------------------------------------------

Cognitive impairment was diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-4).[@R30] Education-adjusted cut-offs of 1.5 SD below the established norms of neuropsychological tests support the diagnosis of CI.[@R31] The norms used were based on a normative study of healthy, cognitively normal, community-dwelling, older adults in China.[@R24] A patient with scores of all the individual neuropsychological tests within the normal range was considered to have no cognitive impairment (NCI).

Statistical analyses {#s2d}
--------------------

Statistical analyses were performed with SPSS Statistics V.20.0 (USA). Between-group comparisons were conducted by using independent sample t-tests for quantitative variables, and a Pearson χ test for categorical variables. Continuous variables, if they were normally distributed, were presented as means±SDs and compared with a two-tailed t-test between two groups. Continuous variables, if they were not normally distributed, were presented as median (quartile) and compared with non-parametric tests. Categorical variables were compared with a χ^2^ test. A receiver operating characteristic (ROC) curve analysis with area under the curve (AUC) was used to compare the discriminatory ability of the MoCA-Beijing in detecting CI.

Results {#s3}
=======

Demographic and clinical characteristics {#s3a}
----------------------------------------

According to the test diagnostic accuracy criteria, the STARDem,[@R32] the flowchart of the study population is shown in [figure 1](#BMJOPEN2016011310F1){ref-type="fig"}. The average age of recruited patients was 53.95±11.43 years, with the majority of patients being men (66.67%). The median of NIHSS score in patients with acute mild stroke was 1.00 point (IQR: 2.00 point(s)). Among the 80 patients with acute mild stroke, approximately half had SAO (n=38, 47.5%), followed by LAA (n=30, 37.5%), CE (n=4, 5.0%), OC (n=4, 5.0%) and UND (n=4, 5.0%). More than half of the sample (58.82%) had cognitive impairment as determined by the formal battery of neuropsychological tests ([table 1](#BMJOPEN2016011310TB1){ref-type="table"}).

###### 

Clinical characteristics of patients with acute mild stroke or TIA within 2 weeks after onset

                                         Total              No cognitive impairment (NCI)   Cognitive impairment (CI)   p Value
  -------------------------------------- ------------------ ------------------------------- --------------------------- -------------
  N                                      102                42                              60                          
  Sex, male (%)                          68/102 (66.67)     29/42 (69.05)                   39/60 (65.00)               0.77
  Age, year, mean (SD)\*                 53.95 (11.43)      47.70 (10.49)                   58.25 (10.04)               \<0.001\*\*
  NIHSS at admission                                                                                                    0.46
   Median (IQR)                          1.00 (2.00)        1.00 (3.00)                     2.00 (2.00)                 
   Premorbid mRS median (IQR)            0.05 (0.34)        0.04 (0.19)                     0.05 (0.29)                 0.76
   Baseline mRS median (IQR)             1.00 (1.00)        1.00 (1.00)                     1.00 (1.00)                 0.19
  Education\*                                                                                                           0.02\*
   Primary school and below (%)          12/102 (11.76)     3/42 (7.14)                     9/60 (15.00)                
   Middle and high school (%)            74/102 (72.55)     28/42 (66.67)                   46/60 (76.67)               
   Bachelor and above (%)                16/102 (15.69)     11/42 (26.19)                   5/60 (8.33)                 
  Stroke classification\*                                                                                               0.046\*
   LAA (%)                               30/80 (37.50)      10/32 (31.25)                   20/48 (41.67)               
   CE (%)                                4/80 (5.00)        3/32 (9.38)                     1/48 (2.08)                 
   SAO (%)                               38/80 (47.50)      13/32 (40.63)                   25/48 (52.08)               
   OC (%)                                4/80 (5.00)        3/32 (9.37)                     1/48 (2.08)                 
   UND (%)                               4/80 (5.00)        3/32 (9.37)                     1/48 (2.08)                 
   TIA (%)                               22/102 (21.57)     10/42 (23.81)                   12/60 (20.00)               0.56
  Medical history, n (%)                                                                                                
   Number of risk factors, mean (SD)     4.57 (2.03)        4.12 (1.84)                     4.88 (2.11)                 0.55
   Hypertension\* (%)                    68/102 (66.67)     23/42 (54.76)                   45/60 (75.00)               0.03\*
   Impaired glucose regulation (%)       34/102 (33.33)     15/42 (35.71)                   19/60 (31.67)               0.18
   Hyperlipidaemia (%)                   79/102 (77.45)     35/42 (83.33)                   44/60 (73.33)               0.54
   Atrial fibrillation (%)               8/102 (7.84)       3/42 (7.14)                     5/60 (8.33)                 0.72
   Coronary heart disease (%)            12/102 (11.76)     5/42 (11.90)                    7/60 (11.67)                0.99
   Hyperhomocysteinaemia (%)             28/102 (27.45)     10/42 (23.81)                   18/60 (30.00)               0.65
   Peripheral arterial disease (%)       21/102 (20.59)     7/42 (16.67)                    14/60 (23.33)               0.47
   Current or ever drinking (%)          73/102 (71.57)     31/42 (73.81)                   42/60 (70.00)               0.82
   Current or ever smoking (%)           69/102 (67.65)     31/42 (73.81)                   38/60 (63.33)               0.81
   Family history of stroke (%)          30/79 (37.97)      9/32 (28.13)                    21/47 (44.68)               0.16
   Prior subcortical stroke or TIA (%)   15/102 (14.71)     4/42 (9.52)                     11/60 (18.33)               0.27
   Anterior circulation (%)              57/102 (55.88)     19/42 (45.24)                   38/60 (63.33)               0.11
   Posterior circulation (%)             45/102 (44.12)     23/42 (54.76)                   22/60 (36.67)               0.07
  Functional status                                                                                                     
   mRS score                             0.00 (0.00∼1.00)   1.00 (1.00∼2.00)                1.00 (0.00--3.00)           0.99
   Instrumental ADL                      8.85 (3.08)        8.08 (0.47)                     9.49 (0.58)                 0.019\*
   Basic ADL                             5.57 (2.58)        5.88 (0.95)                     5.37 (0.42)                 0.23

Mild stroke and TIA patients were divided into cognitive impairment group and no cognitive impairment group according to a battery of neurological tests, including Auditory Verbal Learning Test, Animal Fluency Test, Symbol Digital Modalities Test, Trail Making Test, Stroop Color-Word Test, Rey-Osterrieth Complex Figure Test and Boston Naming Test.

\*p\<0.05; \*\*p\<0.01.

basic ADL, basic activities of daily living; CE, cardioembolism; HAMD, Hamilton depression scale; instrumental ADL, instrumental activities of daily living; LAA, large artery atherosclerosis; mRS, Modified Rankin Scale; NIHSS, National Institute of Health Stroke Scale; OC, stroke of other determined cause; SAO, small artery occlusion; TIA, transient ischaemic attack; UND, undetermined aetiology.

![STARD flow diagram of patient recruitment. \*Montreal Cognitive Assessment (MoCA) abnormal result ≤22 (n=56); +MoCA normal result \>22 (n=46); \#Reference test: neuropsychological battery. §Target condition: cognitive impairment (n=60).](bmjopen2016011310f01){#BMJOPEN2016011310F1}

Demographic information showed that the NCI and CI groups were similar except for age, education, stroke classification, prevalence of hypertension and instrumental ADL. Multivariate analysis showed that age was a significant predictor for CI after minor stroke/TIA ([table 1](#BMJOPEN2016011310TB1){ref-type="table"}).

The discriminant ability of MoCA-Beijing {#s3b}
----------------------------------------

Using ROC analysis, a cut-off point of MoCA-Beijing ≤22 was established to best discriminate CI from NCI ([table 2](#BMJOPEN2016011310TB2){ref-type="table"}). The AUC of MoCA-Beijing was 0.85 (95% CI (0.80 to 0.95)) with good sensitivity (0.85) and specificity in detecting CI (0.88) ([figure 2](#BMJOPEN2016011310F2){ref-type="fig"}).

###### 

Discriminant indices of MoCA in detecting cognitive impairment in patients with acute mild stroke and TIA within 2 weeks after onset

  MoCA      Se %   Sp %   PPV %   NPV %   Correctly classified
  --------- ------ ------ ------- ------- ----------------------
  20/21     0.98   0.58   0.94    0.58    0.70
  21/22     0.95   0.72   0.94    0.71    0.81
  22/23\*   0.85   0.88   0.91    0.80    0.86
  23/24     0.76   0.86   0.84    0.82    0.83
  24/25     0.52   0.93   0.77    0.81    0.78

\*Optimal cutoff score. MoCA, Montreal Cognitive Assessment; NPV, negative predictive value; PPV, positive predictive value; Se, sensitivity; Sp, specificity; TIA, transient ischaemic attack.

![Receiver operating characteristic (ROC) analysis of Montreal Cognitive Assessment (MoCA) for differentiating patients with cognitive impairment from patients without cognitive impairment (22.5; sensibility 85%, specificity 88%, area under curve=0.86).](bmjopen2016011310f02){#BMJOPEN2016011310F2}

Characteristics of neuropsychological impairment {#s3c}
------------------------------------------------

The predominantly impaired cognitive domains were visuomotor speed (n=47, 46.08%), followed by attention/executive function (n=43, 42.16%), visuospatial ability (n=41, 40.20%), visual memory (n=31, 30.39%), language (n=26, 25.49%), verbal immediate-memory (n=31, 22.55%) and verbal delay-memory (n=17, 16.67%) ([table 3](#BMJOPEN2016011310TB3){ref-type="table"}).

###### 

Percentage of each impaired cognitive domain in total patients with acute mild stroke and transient ischaemic attack

  Cognitive domain               Percentage of patients with impaired cognitive domain (%)
  ------------------------------ -----------------------------------------------------------
  Global cognition               55/102 (53.92)
  Visuomotor speed               47/102 (46.08)
  Attention/executive function   43/102 (42.16)
  Visuospatial ability           41/102 (40.20)
  Visual memory                  31/102 (30.39)
  Language                       26/102 (25.49)
  Verbal immediate-memory        23/102 (22.55)
  Verbal delay-memory            17/102 (16.67)

Discussion {#s4}
==========

For the first time, our study used the MoCA-Beijing to screen for cognitive impairment in Chinese patients with mild stroke and TIA in the acute phase. The cut-off point of MoCA-Beijing at 22/23 provided good sensitivity (85%) and specificity (88%) ([table 4](#BMJOPEN2016011310TB4){ref-type="table"}). As recommended by The National Institute of Excellence guidelines,[@R33] MoCA administration within 2 weeks after the mild stroke or TIA event can identify cognitive deficits for early intervention and focused management. Our data provides a useful reference point for a Chinese population.

###### 

A cross-tabulation of the results of the index tests by the results of the reference standard

                            Montreal Cognitive Assessment (MoCA)   
  ------------------------- -------------------------------------- ----
  Cognitive impairment      51                                     9
  No cognitive impairment   5                                      37

The MoCA cut-off score (MoCA-Beijing ≤22) in our study was lower than the commonly recommended cut-off point of 26,[@R26] which may be due to several reasons. First, patient population was different in the original MoCA study by Nasreddine *et al*,[@R26] which recruited 94 MCI or 93 AD patients and 90 controls, while we recruited 102 patients with acute mild stroke/TIA. Second, the education level and age were different between patient samples in the original MoCA study and the present study (education: senior high school vs junior high school; age: 70s vs 50s). Third, the diagnostic criteria for cognitive impairment were different. In the original MoCA study, in which a cut-off of 26 yielded a sensitivity of 0.90 and a specificity of 0.87 to detect MCI, the diagnosis was mainly determined by the memory tests, whereas our neuropsychological test battery included tests covering a number of cognitive domains. These differences in diagnostic criteria might also have contributed to the differences in the cut-off points derived for MoCA. Similarly, other studies on cognitive screening in stroke/TIA patients reported discrepant cut-off MoCA scores from the conventional cut-off point recommended by Nasreddine and colleagues.[@R9] A French study reported the same MoCA cut-off point (≤22) as our own, with good sensitivity (0.84) and specificity (0.81).[@R6] Additionally, a recent meta-analysis reported that MoCA at its conventional cut-off point (\<26/30) had excellent sensitivity (0.95) but low speciﬁcity (0.45). By comparison, adapted MoCA cut-off point (≤22/30) improved speciﬁcity (0.88) while maintaining good sensitivity (0.85).

Our study found that visuomotor speed was the most frequently impaired domain, followed by attention/executive function, visuospatial ability, visual memory, language and verbal memory in patients with acute stroke/TIA. This is consistent with previous studies which report similar characteristics of neuropsychological impairment in patients with stroke.[@R5]

However, our study has some limitations. First, the sample size is relatively small, with the cohort of our patients with stroke being younger than in previous studies. Patients with stroke who were admitted from December 2014 to July 2015 to the Beijing Tiantan Hospital, which is the National Clinical Research Center for Neurological Diseases in China, were aged 53.95±11.43 years. Most patients with stroke admitted in our hospital are non-residents in Beijing, and they are generally younger than the residents in Beijing. Therefore, our findings may not be applicable to all patients with stroke. Second, cognitive function is merely assessed at the acute stroke phase when patients\' cognitive functioning is likely to fluctuate as they undergo spontaneous recovery. Thus, these patients will need a follow-up at 3--6 months after stroke, and their cognitive function reassessed when their recovery is stable. Third, the MoCA scores are influenced by age and education. We are unable to derive age-adjusted and education-adjusted MoCA cut-off points. Future study should include a larger sample and develop age-adjusted and education-adjusted cut-off points for MoCA. Last, frequent impairments in attention/executive function could be due to more tests (total 4) in attention/executive function domain, which may be perceived to impose a circularity effect. However, we classified attention and executive function domains as the same. It is psychometrically acceptable to have two tests in a single domain for reliability. Previous studies on cognition after stroke also included similar neuropsychological tests.[@R21] [@R34]

In conclusion, the MoCA-Beijing is sensitive and specific in detecting CI in patients with acute mild stroke or TIA. Therefore, it should be implemented in routine clinical practice.
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